SOURCES SOUGHT
99 -- 2-PAM Autoinjectors Sources Sought Notice
- Notice Date
- 1/4/2022 12:18:24 PM
- Notice Type
- Sources Sought
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- 2-PAM-BARDA-2022
- Response Due
- 2/7/2022 1:00:00 PM
- Archive Date
- 02/07/2022
- Point of Contact
- Jennifer Taranto, Jonathan Gonzalez
- E-Mail Address
-
jennifer.taranto@hhs.gov, Jonathan.Gonzalez@hhs.gov
(jennifer.taranto@hhs.gov, Jonathan.Gonzalez@hhs.gov)
- Description
- The Office of the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) intends to use responses to this Sources Sought Notice (SSN) for planning potential future acquisitions. BARDA seeks pertinent marketplace data on availabilities and capabilities for procuring, stockpiling, and investing in the late-stage development of Pralidoxime (2-pyridine aldoxime methyl chloride; 2-PAM) autoinjectors for intramuscular injection. BARDA seeks information on availability, capabilities, and other pertinent marketplace data to support late-stage activities required for Food and Drug Administration (FDA) approval of 2-PAM (600 mg) autoinjectors. This information is intended to strengthen BARDA�s understanding of the current and future marketplace and enhance its ability to obtain quality services economically and efficiently, and to lawfully establish potential vendor source files and listings. BARDA will not award any contracts under this Notice.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/4fcd8f0766644742b4f7cb3c097a62c4/view)
- Record
- SN06209304-F 20220106/220104230112 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |